Premarket Decliner
BIVI Biovie2.04+0.21+11.5%
Premarket:1.40-0.64 (-31.4%)
BioVie Announces Topline Results of Phase 2 SUNRISE-PD Trial of Bezisterim in Early Parkinson's Disease
Globe NewswireThu, 6-Aug 7:30 AM
BIVI Biovie2.91-1.00-25.6%
Premarket:1.67-1.24 (-42.6%)
BioVie Inc. Announces Pricing of $12 Million Public Offering
Globe NewswireThu, 7-Aug 8:43 PM
BIVI Biovie3.18+0.55 (+20.9%)
BIVI Biovie6.61+4.26 (+181.3%)
BIVI Biovie0.95-0.12 (-10.8%)
BIVI 1.09-0.80 (-42.3%)Biovie